As shown in Table 4, the association of rs780094 in GCKR with NAFLD was at the border of significance (p = 0.011, OR = 0.82, 95%CI: 0.70–0.91) in the case/control analysis. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.